M Cluzel

544 total citations
32 papers, 461 citations indexed

About

M Cluzel is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, M Cluzel has authored 32 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 12 papers in Molecular Medicine and 6 papers in Infectious Diseases. Recurrent topics in M Cluzel's work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Asthma and respiratory diseases (6 papers). M Cluzel is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Asthma and respiratory diseases (6 papers). M Cluzel collaborates with scholars based in France, United States and United Kingdom. M Cluzel's co-authors include M. Dämon, Jean Bousquet, Pascal Chanez, Philippe Godard, F B Michel, Floyd H. Chilton, Bradley J. Undem, David J. Evans, Brian O’Connor and Peter J. Barnes and has published in prestigious journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and Biochemical Journal.

In The Last Decade

M Cluzel

29 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Cluzel France 11 243 101 97 77 74 32 461
J. Knöller Germany 11 127 0.5× 95 0.9× 174 1.8× 66 0.9× 84 1.1× 30 451
Alfonso Miranda Spain 15 175 0.7× 76 0.8× 70 0.7× 69 0.9× 834 11.3× 22 1.1k
Nirav Daphtary United States 15 273 1.1× 182 1.8× 151 1.6× 163 2.1× 13 0.2× 32 628
Minara Aliyeva United States 15 262 1.1× 226 2.2× 153 1.6× 165 2.1× 12 0.2× 30 660
Kingsley Yin United States 16 73 0.3× 84 0.8× 263 2.7× 131 1.7× 27 0.4× 30 661
Junbo Xia China 12 73 0.3× 66 0.7× 38 0.4× 80 1.0× 59 0.8× 23 421
Yu‐Te Chu Taiwan 10 125 0.5× 68 0.7× 65 0.7× 83 1.1× 24 0.3× 19 353
Annick Thompson Switzerland 12 59 0.2× 30 0.3× 174 1.8× 278 3.6× 41 0.6× 13 751
V. A. Larkin United States 7 128 0.5× 61 0.6× 123 1.3× 87 1.1× 22 0.3× 8 464
Kathryn Welch United States 10 54 0.2× 46 0.5× 167 1.7× 208 2.7× 90 1.2× 14 599

Countries citing papers authored by M Cluzel

Since Specialization
Citations

This map shows the geographic impact of M Cluzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Cluzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Cluzel more than expected).

Fields of papers citing papers by M Cluzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Cluzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Cluzel. The network helps show where M Cluzel may publish in the future.

Co-authorship network of co-authors of M Cluzel

This figure shows the co-authorship network connecting the top 25 collaborators of M Cluzel. A scholar is included among the top collaborators of M Cluzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Cluzel. M Cluzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reid, Donald, G. Nuki, Bernard Avouac, et al.. (1998). Recommendations for the registration of drugs used in the treatment of rheumatoid arthritis. Ghent University Academic Bibliography (Ghent University). 10 indexed citations
2.
Evans, David J., Peter J. Barnes, M Cluzel, & Brian O’Connor. (1997). Effects of a Potent Platelet-activating Factor Antagonist, SR27417A, on Allergen-induced Asthmatic Responses. American Journal of Respiratory and Critical Care Medicine. 156(1). 11–16. 44 indexed citations
3.
Wyld, P.J., et al.. (1994). Single rising oral dose of SR 27417A, a specific PAF receptor antagonist in humans: tolerability and pharmacological assessment.. 10. 155–157. 1 indexed citations
4.
Soussy, Claude–James, et al.. (1994). [In vitro antibacterial activity of a new fluoroquinolone, enoxacin against hospital bacteria and regression curve].. PubMed. 42(4). 274–80. 1 indexed citations
5.
Gant, Vanya, et al.. (1992). Alveolar Macrophage Accessory Cell Function in Bronchial Asthma. American Review of Respiratory Disease. 146(4). 900–904. 29 indexed citations
6.
Chilton, Floyd H., M Cluzel, & Massimo Triggiani. (1991). Recent advances in our understanding of the biochemical interactions between platelet‐activating factor and arachidonic acid. Lipids. 26(12Part1). 1021–1027. 21 indexed citations
7.
Cluzel, M, Mark C. Liu, Daniel Goldman, Bradley J. Undem, & Lawrence M. Lichtenstein. (1990). Histamine Acting on a Histamine Type 1 (H1) Receptor Increases β -Glucuronidase Release from Human Lung Macrophages. American Journal of Respiratory Cell and Molecular Biology. 3(6). 603–609. 13 indexed citations
8.
Cluzel, M, et al.. (1990). Ambulatory long-term subcutaneous salbutamol infusion in chronic severe asthma. Journal of Allergy and Clinical Immunology. 85(3). 599–606. 19 indexed citations
9.
Dämon, M., M Cluzel, Pascal Chanez, & P Godard. (1989). Phagocytosis induction of chemiluminescence and chemoattractant increased superoxide anion release from activated human alveolar macrophages in asthma. Journal of Bioluminescence and Chemiluminescence. 4(1). 279–286. 10 indexed citations
10.
Cluzel, M, Bradley J. Undem, & Floyd H. Chilton. (1989). Release of platelet-activating factor and the metabolism of leukotriene B4 by the human neutrophil when studied in a cell superfusion model.. The Journal of Immunology. 143(11). 3659–3665. 35 indexed citations
11.
Chanal, C., D. Sirot, Marie Chanal, et al.. (1989). Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum  -lactamases. Journal of Antimicrobial Chemotherapy. 24(suppl A). 133–141. 24 indexed citations
12.
Cluzel, M, M. Dämon, Pascal Chanez, et al.. (1987). Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. Journal of Allergy and Clinical Immunology. 80(2). 195–201. 188 indexed citations
13.
Duval, J, et al.. (1986). [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].. PubMed. 34(5 Pt 2). 561–6. 2 indexed citations
14.
Sirot, D., J. Sirot, Patrick Saulnier, et al.. (1986). Resistance to Beta-Lactams in Enterobacteriaceae: Distribution of Phenotypes Related to Beta-Lactamase Production. Journal of International Medical Research. 14(4). 193–199. 6 indexed citations
15.
Chanal, Marie, et al.. (1983). [In vitro study of the bacteriostatic and bactericidal activity of temocillin (BRL 17421)].. PubMed. 31(6). 467–70. 1 indexed citations
16.
Chanal, Marie, et al.. (1979). Suppuration cérébrale aiguë à Hemophilus aphrophilus. Médecine et Maladies Infectieuses. 9(5). 301–305. 3 indexed citations
17.
Chanal, Marie, et al.. (1976). Activité bactéricide de dérivés iodés, in vitro et in vivo sur la peau saine. Médecine et Maladies Infectieuses. 6(11). 451–458. 5 indexed citations
18.
Sirot, J., et al.. (1973). Pouvoir bactéricide des associations d'antibiotiques à base de céphaloridine sur quelques entérobactéries. Médecine et Maladies Infectieuses. 3(4). 169–172. 1 indexed citations
19.
Sirot, J. & M Cluzel. (1972). The role of Neisseria mucosa in pyo genie meningitis of children.. Ann. Inst. Pasteur. 122(1). 53–61. 2 indexed citations
20.
Sirot, J. & M Cluzel. (1972). ["Neisseria mucosa" responsible for purulent meningitis of children].. PubMed. 122(1). 53–61. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Knöller Breakdown of academic impact, for papers by Alfonso Miranda Breakdown of academic impact, for papers by Nirav Daphtary Breakdown of academic impact, for papers by Minara Aliyeva Breakdown of academic impact, for papers by Kingsley Yin Breakdown of academic impact, for papers by Junbo Xia Breakdown of academic impact, for papers by Yu‐Te Chu Breakdown of academic impact, for papers by Annick Thompson Breakdown of academic impact, for papers by V. A. Larkin Breakdown of academic impact, for papers by Kathryn Welch
Rankless by CCL
2026